SANDERCOCK BRETT (Chief Financial Officer) sold 1.2% of their position (1K shares) of RESMED INC on the open market
Open‑market sale worth $224.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/3/2026ACC: 0000943819-26-000020
Officer· Chief Financial Officer
Since Mar 2026
-1K
Net shares
Net seller
$224.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1K disposed
Non-Derivative Transactions1
ResMed Common Stock
Direct
Shares
−1K
Price / share
$224.31
Trade value
$224.31K
% of position
1.2%
4/1/2026
84.50K→83.50K
Total
Net shares
−1K
Net value
-$224.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock Direct | 4/1/2026 | S · Sale | −1K | $224.31 | $224.31K | 1.2% | 84.50K | 83.50K |
| Total | −1K | -$224.31K | ||||||
Derivative Transactions0
No derivative transactions reported